A Long-term Safety Study of Fixed Dose Combination Therapy Fluticasone Furoate/Umeclidinium Bromide/Vilanterol Trifenatate in Japanese Subjects With Asthma

NCT03184987 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: FF/UMEC/VI 100/62.5/25 mcg
DRUG: FF/UMEC/VI 200/62.5/25 mcg
DRUG: Salbutamol
OTHER: ACQ-7

Sponsor

GlaxoSmithKline

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]